Shelly Guest Cermak

Array ( [id] => 3115089 [patent_doc_number] => 05464943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'DNA encoding glycosylated FGF and production thereof' [patent_app_type] => 1 [patent_app_number] => 8/275635 [patent_app_country] => US [patent_app_date] => 1994-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 10845 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464943.pdf [firstpage_image] =>[orig_patent_app_number] => 275635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3003085 [patent_doc_number] => 05371206 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-06 [patent_title] => 'DNA encoding chimeric fibroblast growth factors' [patent_app_type] => 1 [patent_app_number] => 8/177502 [patent_app_country] => US [patent_app_date] => 1994-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7541 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/371/05371206.pdf [firstpage_image] =>[orig_patent_app_number] => 177502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3573542 [patent_doc_number] => 05539094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'DNA encoding Bcl-2-associated proteins' [patent_app_type] => 1 [patent_app_number] => 8/152485 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 10731 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/539/05539094.pdf [firstpage_image] =>[orig_patent_app_number] => 152485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3430479 [patent_doc_number] => 05455338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-03 [patent_title] => 'DNA encoding novel human kunitz-type inhibitors and methods relating thereto' [patent_app_type] => 1 [patent_app_number] => 8/147710 [patent_app_country] => US [patent_app_date] => 1993-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14669 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/455/05455338.pdf [firstpage_image] =>[orig_patent_app_number] => 147710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3491621 [patent_doc_number] => 05470952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'CNTF and IL-6 antagonists' [patent_app_type] => 1 [patent_app_number] => 8/140222 [patent_app_country] => US [patent_app_date] => 1993-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6406 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470952.pdf [firstpage_image] =>[orig_patent_app_number] => 140222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3444371 [patent_doc_number] => 05466783 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-14 [patent_title] => 'Human tissue factor inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/093285 [patent_app_country] => US [patent_app_date] => 1993-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 5620 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/466/05466783.pdf [firstpage_image] =>[orig_patent_app_number] => 093285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2992010 [patent_doc_number] => 05346993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-13 [patent_title] => 'Isolated, large latent complexes of TGF-.beta.2 and TGF-.beta.3, and new binding protein for latent form TGF-.beta.1, TGF-.beta.2 and TGF-.beta.3 LTBP-2' [patent_app_type] => 1 [patent_app_number] => 8/092331 [patent_app_country] => US [patent_app_date] => 1993-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 4186 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/346/05346993.pdf [firstpage_image] =>[orig_patent_app_number] => 092331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3471665 [patent_doc_number] => 05427781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'Method of activating T cells with lymphokine SAF' [patent_app_type] => 1 [patent_app_number] => 8/084996 [patent_app_country] => US [patent_app_date] => 1993-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 6094 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/427/05427781.pdf [firstpage_image] =>[orig_patent_app_number] => 084996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2996537 [patent_doc_number] => 05370870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-06 [patent_title] => 'Method for protection against reactive oxygen species' [patent_app_type] => 1 [patent_app_number] => 8/076087 [patent_app_country] => US [patent_app_date] => 1993-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6158 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/370/05370870.pdf [firstpage_image] =>[orig_patent_app_number] => 076087 [rel_patent_id] =>[rel_patent_doc_number] =>)